Top compounds associated with response to DDB2


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CCLE pan-cancer AAC 0.11 0.01
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.091 0.01
mRNA FSC231 CTRPv2 pan-cancer AAC -0.19 0.01
mRNA CGP-082996 GDSC1000 pan-cancer AAC -0.14 0.01
mRNA AS605240 GDSC1000 pan-cancer AAC 0.085 0.01
mRNA PD-0332991 CCLE pan-cancer AAC 0.12 0.01
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.083 0.01
mRNA BRD-K50799972 CTRPv2 pan-cancer AAC 0.094 0.01
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.01
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.01
Download CSV